Stablepharma officials claim their patented StablevaX™ technology can thermally stabilize and deliver a wide range of vaccines without the requirement for refrigeration. They say their stabilized vaccine solution could eliminate the need for the cold chain and enable stockpiling anywhere in the world. StablevaX is designed to enhance the performance of existing and new vaccines, according to the company.